---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-24-008002"
form_type: "8-K"
ticker: null
cik: "0000887247"
company_name: "DMK PHARMACEUTICALS Corp"
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:21:47.881355+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DMK Pharmaceuticals sells ZIMHI assets for $3.17M; entire board and CEO resign effective June 27, 2024

## Summary
- Sold ZIMHI assets to zmi pharma inc. for $3,170,600 on May 16, 2024, approved by Bankruptcy Court.
- Chairman and CEO Ebrahim Versi resigned as director and CEO effective June 27, 2024.
- All other directors (Birndorf, Desai, Reed, J. Versi) resigned; no disagreements cited.
- General Counsel John Dorbin separated; CFO Seth Cohen named Chief Restructuring Officer.

## SEC filing metadata
- accession: 0001999371-24-008002
- form_type: 8-K
- cik: 0000887247
- company_name: DMK PHARMACEUTICALS Corp
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/dmk-8k_051624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-24-008002
- JSON: https://secwatch.observer/filing/0001999371-24-008002.json
- Plain text: https://secwatch.observer/filing/0001999371-24-008002.txt

## Key facts
- Executive change
  Vickie S. Reed resigned as Director at DMK PHARMACEUTICALS Corp.
  - Action: resigned
  - Role: Director
  source text: Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Jannine C. A. Versi resigned as Director at DMK PHARMACEUTICALS Corp.
  - Action: resigned
  - Role: Director
  source text: Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Meera J. Desai resigned as Director at DMK PHARMACEUTICALS Corp.
  - Action: resigned
  - Role: Director
  source text: Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Seth Cohen changed role as Chief Restructuring Officer at DMK PHARMACEUTICALS Corp.
  - Action: assumed the role of
  - Role: Chief Restructuring Officer
  source text: Effective June 27, 2024, Seth Cohen, the Company’s Chief Financial officer will assume the role of Chief Restructuring Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Ebrahim “Eboo” Versi resigned as Chairman of the Board at DMK PHARMACEUTICALS Corp.
  - Action: resigned
  - Role: Chairman of the Board
  source text: Effective June 27, 2024, Ebrahim “Eboo” Versi, M.D., Ph.D. resigned as Chairman of the Board and as a Director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  John W. Dorbin, Jr. departed as General Counsel and Corporate Secretary at DMK PHARMACEUTICALS Corp.
  - Action: separated
  - Role: General Counsel and Corporate Secretary
  source text: John W. Dorbin, Jr. was also separated from his role as General Counsel and Corporate Secretary of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Howard C. Birndorf resigned as Director at DMK PHARMACEUTICALS Corp.
  - Action: resigned
  - Role: Director
  source text: Additionally, Howard C. Birndorf, Meera J. Desai, Ph.D, NACD.DC, Vickie S. Reed, and Jannine C. A. Versi resigned as Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- Executive change
  Ebrahim “Eboo” Versi departed as Chief Executive Officer at DMK PHARMACEUTICALS Corp.
  - Action: separated
  - Role: Chief Executive Officer
  source text: Also effective June 27, 2024, Mr. Versi was separated from his role as Chief Executive Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
- M&A Transactions
  DMK PHARMACEUTICALS Corp completed a disposition involving zmi pharma inc. for $3,170,600 (closed 2024-05-16).
  - Action: disposition
  - Counterparty: zmi pharma inc.
  - Consideration: $3,170,600
  - Closing: 2024-05-16
  source text: On May 16, 2024, pursuant to an agreement approved by the Bankruptcy Court, the Company sold all of its assets relating to its ZIMHI products and business to zmi pharma inc. for $3,170,600.
  evidence_url: https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.